First study of safety and tolerability of 3,4-methylenedioxymethamphetamine-assisted psychotherapy in patients with alcohol use disorder.
Ben Sessa, Laurie Higbed, Steve O’Brien, Claire Durant, Chloe Sakal, Daniel Titheradge, Tim M Williams, Anna Rose-Morris, Elsa Brew-Girard, Sam Burrows, Chantelle Wiseman, Sue Wilson, James Rickard, David J Nutt
J Psychopharmacol February 18, 2021 DOI: 10.1177/0269881121991792 via PubMed
Summary
AI-generated from the abstractIn a first study of its kind, 3,4-methylenedioxymethamphetamine (MDMA)-assisted psychotherapy was found to be safe and tolerable for patients with alcohol use disorder. The treatment did not raise serious safety concerns and was well tolerated by participants, suggesting that this combined approach warrants further investigation as a potential therapy for alcohol addiction.
Study at a glance
| Characteristics | Clinical trial Peer reviewed |
|---|---|
| Sample size | 20 |
| Population | Patients with alcohol use disorder |
| Topics | Addiction |
| Keywords | Aud Alcoholism Alcohol addiction Alcohol dependence |
| Citations | 123 |
| Key finding | MDMA-assisted psychotherapy was safe and tolerable in patients with alcohol use disorder. |
Abstract
First study of safety and tolerability of 3,4-methylenedioxymethamphetamine-assisted psychotherapy in patients with alcohol use disorder.